Effects of transdermal testosterone in poor responders undergoing IVF: Systematic review and meta-analysis

Reproductive BioMedicine Online

Volumn 25, Issue 5, 2012, Pages 450-459

  González Comadran, Mireia ^a,b   Durán, Montserrat ^b   Solà, Ivan ^c,d   Fábregues, Francisco ^e   Carreras, Ramón ^a,b   Checa, Miguel A ^a,b,f  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Centro de Infertilidad y Reproduccion Humana   (Spain)

Author keywords

IVF; live birth; poor responder; randomized controlled trial; transdermal testosterone

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN; TESTOSTERONE;

EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; META ANALYSIS; METAPHASE; OOCYTE; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ADMINISTRATION, CUTANEOUS; ADULT; BIRTH RATE; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; OVULATION INDUCTION; PREGNANCY; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84868470369     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.07.011     Document Type: Review

References (31)

1. M. Arslan, S. Bocca, S. Mirkin, G. Barroso, L. Stadtmauer, and S. Oehninger Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr Fertil. Steril. 84 2005 555 569
2. J. Balasch, F. Fábregues, J. Peñarrubia, F. Carmona, R. Casamitjana, M. Creus, D. Manau, G. Casals, and J.A. Vanrell Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH Hum. Reprod. 21 2006 1884 1893
3. J.K. Bosdou, C.A. Venetis, E.M. Kolibianakis, K.A. Toulis, D.G. Goulis, and L. Zepiridis The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis Hum. Reprod. Update 18 2012 127 145
4. Deeks, J.J., Higgins, J.P.T., Altman, D.G. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins, J.P.T., Green, S. (Eds.), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. < www.cochrane-handbook.org > (accessed June 12.06.2012).
5. F. Fábregues, J. Peñarrubia, M. Creus, D. Manau, G. Casals, and F. Carmona Transdermal testosterone may improve ovarian response to gonadotrophins in low-responder IVF patients: a randomized, clinical trial Hum. Reprod. 24 2009 349 359
6. R. Fanchin, N. Frydman, M. Even, A.L. Berwanger da Silva, M. Grynberg, and J.M. Ayoubi Androgens and poor responders: are we ready to take the plunge into clinical therapy? Fertil. Steril. 96 2011 1062 1065
7. R.G. Farquharson, E. Jauniaux, and N. Exalto ESHRE Special Interest Group for Early Pregnancy (SIGEP). Updated and revised nomenclature for description of early pregnancy events Hum. Reprod. 20 2005 3008 3011
8. A.P. Ferraretti, A. La Marca, B.C. Fauser, B. Tarlatzis, G. Nargund, and L. Gianaroli ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria Hum. Reprod. 26 2011 1616 1624
9. J.L. Fleiss The statistical basis of meta-analysis Stat. Methods Med. Res. 2 1993 121 145
10. N. Gleicher, A. Weghofer, and D.H. Barad The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment? Reprod. Biol. Endocrinol. 9 2011 116
11. Gotzsche, P.C., 2011. We need access to all data from all clinical trials [editorial]. The Cochrane Library. www.thecochranelibrary.com/details/ editorial/1359903/We-need-access-to-all-data-from-all-clinical-trials.html/ (accessed 8.03.2012).
12. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analysis B.M.J. 327 2003 557 560
13. Higgins, J.P.T., Green, S., 2008. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. < www.cochrane-handbook.org > (accessed 8.03.2012).
14. S.G. Hillier, C.R. Harlow, H.J. Shaw, E.J. Wickings, A.F. Dixson, and J.K. Hodges Cellular aspects of pre-ovulatory folliculogenesis in primate ovaries Hum. Reprod. 3 1988 507 511
15. C. Kailasan, S.D. Keay, P. Wilson, W.C. Ford, and J.M. Jenkins Defining poor ovarian response during IVF cycles, in women aged <40 years and its relationship with treatment outcome Hum. Reprod. 19 2004 1544 1547
16. C.H. Kim, C.M. Howles, and H.A. Lee The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low responders Fertil. Steril. 95 2011 679 683
17. Lehman, R., Loder, E., 2012, in press. Missing clinical trial data. B.M.J. doi: http://dx.doi.org/10.1136/bmj.d8158.
18. Liberati, A., 2012. Need to re-align patient-oriented and commercial and academic research [editorial]. The Cochrane Library. < www. thecochranelibrary.com/details/editorial/1431131/Need-to-re-align-patient- oriented-and-commercial-and-academic-research.html/ > (accessed 8.03.2012).
19. N. Massin, I. Cedrin-Durnerin, C. Coussieu, J. Galey-Fontaine, J.P. Wolf, and J.N. Hugues Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique-a prospective, randomized, double-blind study Hum. Reprod. 21 2006 1204 1211
20. M.F. Mitwally, and R.F. Casper Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders Fertil. Steril. 77 2002 776 780
21. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS. Med. 6 2009 1000097
22. M.E. Nielsen, I.A. Rasmussen, S.G. Kristensen, S.T. Christensen, K. Mollgård, and E. Wreford Andersen In human granulosa cells from small antral follicles, androgen receptor mRNA and androgen levels in follicular fluid correlate with FSH receptor mRNA Mol. Hum. Reprod. 17 2011 63 70
23. N.P. Polyzos, and P. Devroey A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil. Steril. 96 2011 1058 1061
24. P.K. Pradeep, X. Li, H. Peegel, and K.M. Menon Dihydrotestosterone inhibits granulosa cell proliferation by decreasing the cyclin D2 mRNA expression and cell cycle arrest at G1 phase Endocrinology 143 2002 2930 2935
25. H.N. Sallam, F. Ezzeldin, A.F. Agameya, A.F. Rahman, and Y. El-Garem Defining poor responders in assisted reproduction Int. J. Fertil. Womens Med. 50 2005 115 120
26. S.K. Sunkara, J. Pundir, and Y. Khalaf Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis Reprod. Biomed. Online 22 2011 545 555
27. N.O. Turhan Poor response-the devil is in the definition Fertil. Steril. 86 2006 777
28. K. Vendola, J. Zhou, J. Wang, O.A. Famuyiwa, M. Bievre, and C.A. Bondy Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary Biol. Reprod. 61 1999 353 357
29. B. Vollenhoven, T. Osianlis, and J. Catt Is there an ideal stimulation regimen for IVF for poor responders and does it change with age? J. Assist. Reprod. Genet. 25 2008 523 529
30. S. Weil, K. Vendola, J. Zhou, and C.A. Bondy Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development J. Clin. Endocrinol. Metab. 84 1999 2951 2956
31. F. Zegers-Hochschild, G.D. Adamson, J. de Mouzon, O. Ishihara, R. Mansour, and K. Nygren International Committee for Monitoring Assisted Reproductive Technology; World Health Organization. The International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) Revised Glossary on ART Terminology Fertil. Steril. 92 2009 1520 1524